TMDX-35.61%24.0%
SRTA+51.16%19.0%
GMRS-18.47%14.0%
PHIG+18.52%12.0%
MODV0.00%10.0%
TXT+14.27%10.0%
CDNA+247.33%8.0%
CJT.TO-10.82%3.0%
As of Aug 6, 2026, 4:25 AM ET
Freight Transport '26: Medical Transport Constituents
TransMedics Group, Inc.TMDX | 24.0% | -5.28% | 5.85% | 7.38% | -0.03% | -37.12% | -47.34% | 4.62% | -35.61% | $2.64B |
Strata Critical Medical, Inc.SRTA | 19.0% | 5.03% | 16.07% | 7.54% | 16.53% | 21.62% | 36.68% | 106.71% | 51.16% | $506.2M |
GMR Solutions Inc.GMRS | 14.0% | -2.16% | -5.71% | -14.95% | -5.05% | -18.47% | -18.47% | -18.47% | -18.47% | $560.1M |
PHI Group, Inc.PHIG | 12.0% | -3.11% | -3.06% | 3.33% | -3.12% | 11.11% | -3.11% | 57.17% | 18.52% | $753.6M |
ModivCare Inc.MODV | 10.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $447.7M |
Textron Inc.TXT | 10.0% | -0.74% | -7.40% | -5.73% | 3.75% | 1.50% | -10.31% | 22.16% | 14.27% | $15.21B |
CareDx, IncCDNA | 8.0% | -3.38% | 22.51% | 56.57% | 4.10% | 141.51% | 142.54% | 147.42% | 247.33% | $2.35B |
Cargojet Inc.CJT.TO | 3.0% | 0.16% | 4.29% | 3.80% | 5.00% | 3.96% | -9.09% | 11.40% | -10.82% | $944.1M |
| Theme return | — | -1.33% | 4.48% | 7.67% | 3.32% | 4.79% | -1.86% | 49.52% | 15.67% | — |
| Average | 12.5% | -1.18% | 4.07% | 7.24% | 2.65% | 15.51% | 11.36% | 41.38% | 33.30% | $2.93B |
| Median | 11.0% | -1.45% | 2.15% | 3.57% | 1.88% | 2.73% | -6.10% | 16.78% | 7.14% | $848.8M |
| Std Dev | 6.1% | 2.92% | 9.89% | 19.92% | 6.21% | 50.53% | 54.10% | 54.40% | 84.55% | $4.71B |
| Min | 3.0% | -5.28% | -7.40% | -14.95% | -5.05% | -37.12% | -47.34% | -18.47% | -35.61% | $447.7M |
| Max | 24.0% | 5.03% | 22.51% | 56.57% | 16.53% | 141.51% | 142.54% | 147.42% | 247.33% | $15.21B |
| % Positive Tickers | 25.00% | 50.00% | 62.50% | 50.00% | 62.50% | 25.00% | 75.00% | 50.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Freight Transport '26: Medical Transport tracks 8 publicly listed stocks in this theme: CDNA, CJT.TO, GMRS, MODV, PHIG, SRTA, TMDX, TXT. See the constituent table for details.